"AnMed Health is a dynamic, comprehensive health system in Anderson, S.C. For more than 100 years, AnMed Health has provided health care for residents of eight counties in upstate South Carolina and northeast Georgia. AnMed Health’s medical staff includes more than 400 physicians. At AnMed Health, we're committed to bringing expert care close to home."

During the past decade, AnMed Health Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 67 clinical trials were completed, i.e. on average, 239.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 21 clinical trials were completed. i.e. 190.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AnMed Health Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "Medtronic Vascular" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored, "Actelion" with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AnMed Health Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "AnMed Health Hospital" are "Coronary Artery Disease" (15 trials), "Pulmonary Arterial Hypertension" (6 trials), "Acute Coronary Syndrome" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Coronary Artery Stenosis" (4 trials). Many other conditions were trialed in "AnMed Health Hospital" in a lesser frequency.

Most popular intervention types in "AnMed Health Hospital" are "Drug" (70 trials), "Other" (39 trials), "Biological" (27 trials), "Device" (22 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Bevacizumab" (16 trials), "Paclitaxel" (13 trials), "Quality-of-Life Assessment" (13 trials) and "Placebo" (10 trials). Other intervention names were less common.

The vast majority of trials in "AnMed Health Hospital" are 82 trials for "All" genders, 19 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AnMed Health Hospital". undefined are not yet recruiting, 5 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in AnMed Health Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in AnMed Health Hospital, 6 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 20 trials that are defined as “Not Applicable".

AnMed Health Hospital has several departments that took part in Clinical trials: "AnMed Cancer Center" - 85 trials, "AnMed Health Cancer Center" - 152 trials, "Anderson Gastroenterology Associates, LLC" - 5 trials, "AnMed Health Clinical Research" - 4 trials, "AnMed Health Pulmonary and Sleep Medicine" - 4 trials